News and Features
FDA Updates Saquinavir Labeling
“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir."
“Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.”
The updated labeling will be available at the FDA website.
More information is available:
Recent HIV/AIDS News from FDA and NIAID
- December 21, 2015: FDA Updates Blood Donor Deferral Policy to Reflect the Most Current Scientific Evidence and Continue to Ensure the Safety of the U.S. Blood Supply
- December 21, 2015: Final Guidance: “Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products”
- December 23, 2015: HIV Antibody Infusion Safely Suppresses Virus in Infected People